Sweden· SE-20020620000017
Pegasys 135 mikrogram Injektionsvätska, lösning
A medicinal product containing peginterferon alfa-2a, registered in Sweden by Roche Registration Ltd.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Peginterferon Alfa-2a
- Manufacturer
- Roche Registration Ltd
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- August 27, 2026
Packs & prices · 1
- se_varunummer20020620000017
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Peginterferon alfa-2a in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainPEGASYS 135 microgramos SOLUCION INYECTABLE EN PLUMA PRECARGADAZr Pharma & Gmbh
- BelgiumPegasys 135 µgRoche Registration
- CzechiaPEGASYSpharmaand GmbH, Vienna
- NorwayPegasyspharmaand GmbH
- FinlandPegasysOrifarm Oy
- United StatesPegasyspharmaand GmbH
- United KingdomPegasys 135micrograms/0.5ml solution for injection pre-filled pensRoche Products Ltd
- IcelandPegasysPharmaand GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Pegasys
- Liechtenstein · Pegasys
- Norway · Pegasys
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/95f7f7a5-45fa-4edd-839e-e1eb499b879d GET /v1/drugs/95f7f7a5-45fa-4edd-839e-e1eb499b879d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EMA",
"EPAR"
],
"se_npl_id": "20020620000017",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20020620000017",
"product_doc_link": "https://www.ema.europa.eu/en/medicines/human/EPAR/pegasys"
}See everything about peginterferon alfa-2a.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.